0141 352 98 55

25 Blythswood Square, Glasgow, G2 4BL

Patient centricity – being taken seriously?
May 3, 2018
Patient centric data from Medsmart

Patient centricity is a hot topic in the press. From reading this month’s PharmaTimes @PharmaTimes there was a really interesting introduction by the Editor and piece asking “… whether pharma is truly walking the patient centric walk despite years of talking the talk, and if not, what it can do to get there.” This emerging approach is the belief that the empowered patient is on the rise.

How is patient centricity defined? We at Talking Medicines @TMedicines @GoMedsmartfocus on listening to the needs of the consumers, which includes patients and their families, and our customers to what they want and what kinds of insight would be valuable. We have developed a tool called Medsmart® that has real value to consumers, HCPs and the pharmaceutical industry.

One area that we are keen to connect with are the key performance indicators to clearly show the importance and return on investment for companies to be patient centric. There are multiple routes here to explore – engaging with patients to gain insight for drug development at a clinical trial level, product or device development and, the area that Medsmart® primarily sits, how and what medicines patients are actually taking for their multiple health conditions. Medsmart® being a UK community based consumer insights tool gathers qualitative data that can be used by companies post-launch, in the early years to position and grow their market share of their products.

Talking Medicines is a data tech company that sells consumer medicines data for good to drive more effective use of medicines. We are keen to connect with the brand marketing leads within Pharmaceutical Companies to help them to explore the full potential of patient engagement through Medsmart®. Please get in touch with us if you would like to arrange a demo through [email protected] on insights data for the medicines that are of interest to you.

Recent Blogs

Appointment of Head of Data Quality

Appointment of Head of Data Quality

Data insights firm Talking Medicines, specialist in ‘social intelligence’ for the pharmaceutical industry, has appointed Donna Lawson to the position of Head of Data Quality. A particularly good fit for the role, Donna brings with her over two decades’ experience...

The effect of self-diagnosis on patient outcomes

The effect of self-diagnosis on patient outcomes

The internet is a wonderful place. You can find photos of places you want to visit, maps of your favourite mountain ranges, tutorials on how to bake the perfect birthday cake…the list goes on. In recent years, however, there has been a marked increase in the number of...

Pharma Business International Interview

Pharma Business International Interview

Pharma Business International spoke with Jo Halliday, CEO of Talking Medicines, the world’s first social intelligence company designed specifically for the pharmaceutical industry.  The full article can be found here on page 10-11 Tell us about Talking Medicines?...

Tracking Covid vaccine progress through Medsmart®

Tracking Covid vaccine progress through Medsmart®

In the race against new super spreading virus variants, the UK among other countries have implemented a fast streamed vaccine programme to protect the vulnerable as quickly as possible. Since the beginning of January, 17,916,181 people in the UK have been given their...